Bone Marrow TransplantationBone MarrowSyndromeTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityCyclophosphamideBone Marrow DiseasesTransplantation, IsogeneicTreatment OutcomeKidney TransplantationRecurrenceTime FactorsHematopoiesisCombined Modality TherapyAcute DiseaseMice, Inbred C57BLMyelodysplastic SyndromesRadiation ChimeraLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow ExaminationRetrospective StudiesImmunosuppressive AgentsRemission InductionHematologic NeoplasmsGraft RejectionHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaBone RemodelingBone Marrow NeoplasmsLeukemia, MyeloidTransplantation ImmunologyCentral Cord SyndromeGraft vs Host ReactionImmunosuppressionLymphocyte DepletionStem Cell TransplantationFatal OutcomeLymphoma, Non-HodgkinLeukocyte TransfusionHeart TransplantationFollow-Up StudiesSevere Combined ImmunodeficiencyT-LymphocytesSurvival AnalysisChimeraColony-Forming Units AssayHLA AntigensLung TransplantationDown SyndromeHematologic DiseasesCyclosporineBone DensityActuarial AnalysisMetabolic Syndrome XLymphocyte TransfusionNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsPancytopeniaPrognosisCarmustineOrgan TransplantationCell DifferentiationLeukocyte CountSurvival RateDisease Models, AnimalGraft vs Tumor EffectProspective StudiesCytarabineCytomegalovirus InfectionsRisk FactorsGraft vs Leukemia EffectPhenotypeSpleenGranulocyte Colony-Stimulating FactorBone ResorptionMice, Inbred BALB CMelphalanDisease-Free SurvivalFlow CytometryCells, CulturedImmunologic Deficiency SyndromesPolymerase Chain Reaction